These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10696827)

  • 1. The responsiveness of the Hamilton Depression Rating Scale.
    Faries D; Herrera J; Rayamajhi J; DeBrota D; Demitrack M; Potter WZ
    J Psychiatr Res; 2000; 34(1):3-10. PubMed ID: 10696827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262(4):291-304. PubMed ID: 21959915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos.
    Santor DA; Debrota D; Engelhardt N; Gelwicks S
    Depress Anxiety; 2008; 25(9):774-86. PubMed ID: 17935212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing HAMD(17) and HAMD subscales on their ability to differentiate active treatment from placebo in randomized controlled trials.
    Boessen R; Groenwold RH; Knol MJ; Grobbee DE; Roes KC
    J Affect Disord; 2013 Mar; 145(3):363-9. PubMed ID: 22959683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inventory Of Depressive Symptomatology (IDS-C(28)) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD(17)) in patients with mild major, minor or subsyndromal depression.
    Helmreich I; Wagner S; Mergl R; Allgaier AK; Hautzinger M; Henkel V; Hegerl U; Tadić A
    Eur Arch Psychiatry Clin Neurosci; 2011 Aug; 261(5):357-67. PubMed ID: 21132437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.
    Lin CH; Chen CC; Wang FC; Lane HY
    Psychiatry Clin Neurosci; 2013 May; 67(4):265-72. PubMed ID: 23683158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
    J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis.
    Workman EA; Short DD
    J Clin Psychiatry; 1993 Jan; 54(1):5-12. PubMed ID: 8428898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
    Zimmerman M; Walsh E; Chelminski I; Dalrymple K
    J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
    Bech P
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
    Schulz V
    Phytomedicine; 2002 Jul; 9(5):468-74. PubMed ID: 12222670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity classification on the Hamilton Depression Rating Scale.
    Zimmerman M; Martinez JH; Young D; Chelminski I; Dalrymple K
    J Affect Disord; 2013 Sep; 150(2):384-8. PubMed ID: 23759278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
    Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F
    Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.
    Helmreich I; Wagner S; König J; Kohnen R; Szegedi A; Hiemke C; Tadić A
    J Affect Disord; 2015 Apr; 175():199-208. PubMed ID: 25638793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.
    Strik JJ; Honig A; Lousberg R; Lousberg AH; Cheriex EC; Tuynman-Qua HG; Kuijpers PM; Wellens HJ; Van Praag HM
    Psychosom Med; 2000; 62(6):783-9. PubMed ID: 11138997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.